Stock listing
Knight Therapeutics, Inc.
Selected listing: A1XE7A · LS · EUR · DE
Knight Therapeutics, Inc. (Lang & Schwarz: A1XE7A), Health Technology. Latest release Oct 6, 2026: Knight Therapeutics Announces Regulatory Approval…
- Ticker
- Lang & Schwarz: A1XE7A
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Knight Therapeutics, Inc.
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
October 6, 2026
Knight Therapeutics Announces Launch of TAVALISSE® in Brazil
October 6, 2026
Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)
September 29, 2026
Knight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada's Top Growing Companies
September 25, 2026
Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada
September 15, 2026
Events
Research Knight Therapeutics, Inc.
Knight Therapeutics, Inc. company profile
View the public company page for Knight Therapeutics, Inc. on 6ix.
Knight Therapeutics, Inc. news
Read company news and market updates connected to Knight Therapeutics, Inc..
Knight Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Knight Therapeutics, Inc..
Alternate listings
GUD:TSX
CA · CAD
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
KHTRF:OTC
US · USD
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
GUD:NEO
CA · CAD
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
A1XE7A:LSX
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
04K:GETTEX
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
04K:FWB
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
04K:DUS
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
04K:MUN
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
04K:SWB
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.
04K:TRADEGATE
DE · EUR
Alternate listing for Knight Therapeutics, Inc.; the primary context on this page is A1XE7A:LS.